BIOGEN INC. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOGEN INC. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | A | 0.00 | 26,550 | 0 | 26,550 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | A | 0.00 | 6,220 | 0 | 6,220 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 7,260 | 0 | 7,260 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | A | 0.00 | 3,110 | 0 | 3,110 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 1,300 | 0 | 1,300 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 5,190 | 0 | 5,190 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | A | 0.00 | 8,300 | 0 | 8,300 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech. and Bus. ... | Option Exercise | A | 0.00 | 4,460 | 0 | 4,460 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | A | 0.00 | 5,190 | 0 | 5,190 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | A | 0.00 | 2,700 | 0 | 2,700 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | A | 0.00 | 5,700 | 0 | 5,700 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 600 | 0 | 600 | |
| Feb 25 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 5,700 | 0 | 5,700 | |
| Feb 20 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 401.04 | 537 | 215,358 | 46,538 | 47.1 K to 46.5 K (-1.14 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 389.11 | 825 | 321,016 | 47,075 | 47.9 K to 47.1 K (-1.72 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Sell | S | 389.11 | 2,128 | 828,026 | 4,321 | 6.4 K to 4.3 K (-33.00 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 389.11 | 418 | 162,648 | 15,004 | 15.4 K to 15 K (-2.71 %) |
| Feb 18 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Sell | S | 389.11 | 1,188 | 462,263 | 803 | 2 K to 803 (-59.67 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | J | 0.00 | 4,093 | 0 | 20,996 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,401 | 0 | 25,089 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,198 | 0 | 18,371 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 392.11 | 4,781 | 1,874,678 | 47,900 | 52.7 K to 47.9 K (-9.08 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Grant | A | 0.00 | 10,149 | 0 | 52,681 | 42.5 K to 52.7 K (+23.86 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 392.11 | 3,015 | 1,182,212 | 42,532 | 45.5 K to 42.5 K (-6.62 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 6,401 | 0 | 45,547 | 39.1 K to 45.5 K (+16.35 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 392.11 | 4,329 | 1,697,444 | 39,146 | 43.5 K to 39.1 K (-9.96 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 9,198 | 0 | 43,475 | 34.3 K to 43.5 K (+26.83 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 100 | 0 | 514 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 156 | 0 | 614 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 315 | 0 | 630 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 392.11 | 4 | 1,568 | 1,446 | 1.5 K to 1.4 K (-0.28 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 156 | 0 | 1,450 | 1.3 K to 1.5 K (+12.06 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 392.11 | 16 | 6,274 | 1,294 | 1.3 K to 1.3 K (-1.22 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 315 | 0 | 1,310 | 995 to 1.3 K (+31.66 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | J | 0.00 | 954 | 0 | 4,894 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 1,492 | 0 | 5,848 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,142 | 0 | 4,289 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 392.11 | 703 | 275,653 | 6,449 | 7.2 K to 6.4 K (-9.83 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 1,492 | 0 | 7,152 | 5.7 K to 7.2 K (+26.36 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 392.11 | 1,009 | 395,639 | 5,660 | 6.7 K to 5.7 K (-15.13 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,142 | 0 | 6,669 | 4.5 K to 6.7 K (+47.32 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | J | 0.00 | 311 | 0 | 1,602 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 487 | 0 | 1,913 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 714 | 0 | 1,430 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 392.11 | 159 | 62,345 | 1,159 | 1.3 K to 1.2 K (-12.06 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 487 | 0 | 1,318 | 831 to 1.3 K (+58.60 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 392.11 | 235 | 92,146 | 831 | 1.1 K to 831 (-22.05 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 714 | 0 | 1,066 | 352 to 1.1 K (+202.84 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | J | 0.00 | 519 | 0 | 2,668 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 813 | 0 | 3,187 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 792 | 0 | 1,589 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 392.11 | 383 | 150,178 | 15,422 | 15.8 K to 15.4 K (-2.42 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 813 | 0 | 15,805 | 15 K to 15.8 K (+5.42 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 392.11 | 374 | 146,649 | 14,992 | 15.4 K to 15 K (-2.43 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 792 | 0 | 15,366 | 14.6 K to 15.4 K (+5.43 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 954 | 0 | 4,894 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 1,492 | 0 | 5,848 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,807 | 0 | 5,615 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 392.11 | 703 | 275,653 | 22,257 | 23 K to 22.3 K (-3.06 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 1,492 | 0 | 22,960 | 21.5 K to 23 K (+6.95 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 392.11 | 1,323 | 518,762 | 21,468 | 22.8 K to 21.5 K (-5.80 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,807 | 0 | 22,791 | 20 K to 22.8 K (+14.05 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 954 | 0 | 4,894 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 1,492 | 0 | 5,848 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 2,246 | 0 | 4,495 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 392.11 | 703 | 275,653 | 32,511 | 33.2 K to 32.5 K (-2.12 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 1,492 | 0 | 33,214 | 31.7 K to 33.2 K (+4.70 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 392.11 | 1,058 | 414,852 | 31,722 | 32.8 K to 31.7 K (-3.23 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 2,246 | 0 | 32,780 | 30.5 K to 32.8 K (+7.36 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | J | 0.00 | 1,041 | 0 | 5,342 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 1,627 | 0 | 6,383 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 3,573 | 0 | 7,149 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 392.11 | 767 | 300,748 | 15,658 | 16.4 K to 15.7 K (-4.67 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 1,627 | 0 | 16,425 | 14.8 K to 16.4 K (+10.99 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 392.11 | 1,683 | 659,921 | 14,798 | 16.5 K to 14.8 K (-10.21 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 3,573 | 0 | 16,481 | 12.9 K to 16.5 K (+27.68 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | J | 0.00 | 1,041 | 0 | 5,342 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 1,627 | 0 | 6,383 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,142 | 0 | 4,289 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 392.11 | 767 | 300,748 | 27,867 | 28.6 K to 27.9 K (-2.68 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 1,627 | 0 | 28,634 | 27 K to 28.6 K (+6.02 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 392.11 | 1,009 | 395,639 | 27,007 | 28 K to 27 K (-3.60 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,142 | 0 | 28,016 | 25.9 K to 28 K (+8.28 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 970 | 0 | 4,982 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 1,518 | 0 | 5,952 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,246 | 0 | 4,495 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 392.11 | 715 | 280,359 | 1,991 | 2.7 K to 2 K (-26.42 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 1,518 | 0 | 2,706 | 1.2 K to 2.7 K (+127.78 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 392.11 | 1,058 | 414,852 | 1,188 | 2.2 K to 1.2 K (-47.11 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,246 | 0 | 2,246 | 0 to 2.2 K |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | J | 0.00 | 867 | 0 | 4,448 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 1,355 | 0 | 5,315 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 2,246 | 0 | 4,495 | |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 392.11 | 639 | 250,558 | 8,132 | 8.8 K to 8.1 K (-7.29 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 1,355 | 0 | 8,771 | 7.4 K to 8.8 K (+18.27 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 392.11 | 1,058 | 414,852 | 7,416 | 8.5 K to 7.4 K (-12.49 %) |
| Feb 17 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 2,246 | 0 | 8,474 | 6.2 K to 8.5 K (+36.06 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 400.22 | 100 | 40,022 | 14,574 | 14.7 K to 14.6 K (-0.68 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 399.08 | 100 | 39,908 | 14,674 | 14.8 K to 14.7 K (-0.68 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 398.10 | 643 | 255,975 | 14,774 | 15.4 K to 14.8 K (-4.17 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 397.11 | 300 | 119,134 | 15,417 | 15.7 K to 15.4 K (-1.91 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 18,833 | 0 | 0 | |
| Feb 11 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,270 | 0 | 11,274 | |
| Feb 11 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 395.13 | 8,871 | 3,505,198 | 34,277 | 43.1 K to 34.3 K (-20.56 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 18,833 | 0 | 43,148 | 24.3 K to 43.1 K (+77.45 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 396.88 | 4,940 | 1,960,587 | 24,315 | 29.3 K to 24.3 K (-16.89 %) |
| Feb 11 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 11,270 | 0 | 29,255 | 18 K to 29.3 K (+62.66 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 3,468 | 0 | 3,471 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 402.00 | 1,634 | 656,868 | 12,908 | 14.5 K to 12.9 K (-11.24 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 3,468 | 0 | 14,542 | 11.1 K to 14.5 K (+31.32 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 3,909 | 0 | 0 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,498 | 0 | 2,498 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 396.88 | 1,842 | 731,053 | 25,874 | 27.7 K to 25.9 K (-6.65 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 3,909 | 0 | 27,716 | 23.8 K to 27.7 K (+16.42 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 402.00 | 818 | 328,836 | 23,807 | 24.6 K to 23.8 K (-3.32 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,498 | 0 | 24,625 | 22.1 K to 24.6 K (+11.29 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 1,824 | 0 | 0 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 1,277 | 0 | 1,278 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 396.88 | 681 | 270,275 | 15,717 | 16.4 K to 15.7 K (-4.15 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 1,824 | 0 | 16,398 | 14.6 K to 16.4 K (+12.52 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 398.05 | 856 | 340,731 | 14,574 | 15.4 K to 14.6 K (-5.55 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 402.00 | 421 | 169,242 | 15,430 | 15.9 K to 15.4 K (-2.66 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 1,277 | 0 | 15,851 | 14.6 K to 15.9 K (+8.76 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,705 | 0 | 2,709 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 402.00 | 1,275 | 512,550 | 4,527 | 5.8 K to 4.5 K (-21.98 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,705 | 0 | 5,802 | 3.1 K to 5.8 K (+87.34 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 1,824 | 0 | 0 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 2,636 | 0 | 2,639 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 396.88 | 860 | 341,317 | 6,228 | 7.1 K to 6.2 K (-12.13 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 1,824 | 0 | 7,088 | 5.3 K to 7.1 K (+34.65 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 402.00 | 883 | 354,966 | 5,264 | 6.1 K to 5.3 K (-14.36 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 2,636 | 0 | 6,147 | 3.5 K to 6.1 K (+75.08 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 4,691 | 0 | 0 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 4,023 | 0 | 4,026 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 396.88 | 2,210 | 877,105 | 30,534 | 32.7 K to 30.5 K (-6.75 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 4,691 | 0 | 32,744 | 28.1 K to 32.7 K (+16.72 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 402.00 | 1,537 | 617,874 | 28,053 | 29.6 K to 28.1 K (-5.19 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 4,023 | 0 | 29,590 | 25.6 K to 29.6 K (+15.74 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,691 | 0 | 0 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 3,191 | 0 | 3,194 | |
| Feb 10 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 396.88 | 2,210 | 877,105 | 19,984 | 22.2 K to 20 K (-9.96 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,691 | 0 | 22,194 | 17.5 K to 22.2 K (+26.80 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 402.00 | 1,143 | 459,486 | 17,503 | 18.6 K to 17.5 K (-6.13 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 3,191 | 0 | 18,646 | 15.5 K to 18.6 K (+20.65 %) |
| Feb 10 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Gift | G | 0.00 | 250 | 0 | 5,450 | 5.7 K to 5.5 K (-4.39 %) |
| Feb 03 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Sell | S | 389.03 | 1,656 | 644,234 | 0 | 1.7 K to 0 (-100.00 %) |
| Feb 02 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,463 | 0 | 2,467 | |
| Feb 02 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 389.16 | 807 | 314,052 | 1,656 | 2.5 K to 1.7 K (-32.76 %) |
| Feb 02 2015 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,463 | 0 | 2,463 | 0 to 2.5 K |
| Feb 02 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 5,157 | 0 | 0 | |
| Feb 02 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 389.16 | 2,059 | 801,280 | 11,074 | 13.1 K to 11.1 K (-15.68 %) |
| Feb 02 2015 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 5,157 | 0 | 13,133 | 8 K to 13.1 K (+64.66 %) |
| Feb 02 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 5,157 | 0 | 0 | |
| Feb 02 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 389.16 | 2,060 | 801,670 | 3,097 | 5.2 K to 3.1 K (-39.95 %) |
| Feb 02 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 5,157 | 0 | 5,157 | 0 to 5.2 K |